| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |